mu agonist/CCR5 antagonist (University of Minnesota)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemu agonist/CCR5 antagonist (University of Minnesota)
Drug Alias NameMCC-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 5 antagonistsMu opioid receptor agonists
TargetsMu opioid receptorC-C chemokine receptor type 5
Therapy Area/IndicationsInflammationNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Minnesota
Active IndicationsN/A
Inactive IndicationsInflammationNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A